Abstract

Research Article

Coronaviruses have reached at Pre-elimination Stage with Nine Amino Acid Spike Deletions and Forty-nine Nucleotide 3’-UTR Deletions

Asit Kumar Chakraborty*

Published: 17 September, 2024 | Volume 8 - Issue 2 | Pages: 031-044

Background: Human 30kb coronaviruses entered through the ACE-2 receptors causing fibrosis of the lungs and causing six million deaths worldwide. Here, we have investigated the mutations, deletions and insertions of the recent JN.1 omicron coronaviruses to demonstrate that coronaviruses have reached the pre-elimination stage. 
Methods: We multi-aligned the genomes of recent JN.1 variants using NCBI Virus Portal and CLUSTAL-Omega. The spike proteins are multi-aligned using MultAlin software and CLUSTAL-Omega.
Results: The 17MPLF spike insertion was confirmed to compensate 24LPP, 31S, 69HV, 145Y, 211N and 483V deletions. The 49nt deletions in the 3’-UTR were found in 4997 JN.1 sequences although 26nt deletion was initiated previously in JN.1 as well as BA.5, BF.7, BQ.1 and XBB.1.5 omicron viruses. We first compare 3-D structures of spike proteins with or without 17MPLF four amino acids insertion and nine amino acids deletions using SWISS MODELLING. The JN.1 viruses caused a more stable trimeric spike involving Thr342, Lys436, Lys440, His441, Ser442, Gly443, Tyr445, Lys479, Ser489, Tyr490, Arg493, Pro494, Thr495, and Gln501 amino acids to interact with ACE-2 receptors. The FLiRT spike mutations were found in most KP.2 variants and other changes occurred at the NH2 terminus.
Conclusion: We claimed that pre-death changes were initiated in JN.1 COVID-19 lineages and computer simulation showed that the Howard spike with 17MPLF spike insertion appeared more stable than the Oppentrons-spike without 17MPLF insertion. Surely, conflicts of COVID-19 spike sequences must be resolved.

Read Full Article HTML DOI: 10.29328/journal.ijcv.1001060 Cite this Article Read Full Article PDF

Keywords:

COVID-19 pre-elimination stage; Spike 17MPLF insertion mutants; 31S spike deletion; KP.2 subvariant; 49nt deletion in 3’-UTR; Fraudulent data deposition

References

  1. Lu R, Zhao X, Li J, Niu P, Yang B, Wang W, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565-574. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30251-8/fulltext
  2. Peiris M, Poon LLM. Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) (Coronaviridae). In: Encyclopedia of Virology. 2021;814–824. Available from: https://doi.org/10.1016%2FB978-0-12-814515-9.00138-7
  3. Chakraborty AK. Conversion of B.0 lineage of human coronavirus (Covid-19) into notoriously infecting less pathogenic and immune escape omicron B.1.1.529.2.75.2 or BA.2.75.2 variant. J Biomed Res Reports. 2023;2(10). Available from: https://crimsonpublishers.com/cjmi/pdf/CJMI.000648.pdf
  4. Lu G, Wang Q, Gao GF. Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol. 2015;23:468-478. Available from: https://doi.org/10.1016/j.tim.2015.06.003
  5. Chakraborty AK, Chanda A. New Biotechnological Exploration on COVID-19 Proteins: Functions, Mutational Profiles and Molecular Targets for Drug Design. Sun Text Rev Virol. 2021;2(1):115. Available from: http://dx.doi.org/10.51737/2766-5003.2021.015
  6. Das S, Kar SS, Samanta S, J. Banerjee, Giri B, Dash SK, et al. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review. Immunol Rs. 2022;70(3):289-315. Available from: https://doi.org/10.1007%2Fs12026-022-09265-0
  7. Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3-20. Available from: https://doi.org/10.1038/s41580-021-00418-x
  8. Huang N, Pérez P, Kato T, Mikami Y, Okuda K. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2021;27(5):892-903. Available from: https://doi.org/10.1038/s41591-021-01296-8
  9. Chakraborty AK. Hyper-variable Spike Protein of Omicron Corona Virus and its differences with Alpha and Delta Variants: Prospects of RT-PCR and new Vaccine. J Emerg Dis Virol. 2022;7(1):1-13. Available from: https://www.sciforschenonline.org/journals/virology/article-data/JEDV166/JEDV166.pdf
  10. Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Montefiori DC, et al. Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182:812-827. Available from: https://doi.org/10.1016/j.cell.2020.06.043
  11. Liu Y, Liu J, Plante KS, Plante JA, Xie X, Zhang X, et al. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature. 2022;602(7896):294-299. Available from: https://doi.org/10.1038/s41586-021-04245-0
  12. Gobeil S, Janowska K, McDowell S, Mansouri K, Parks R, Stalls V, et al. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Science. 2021;373(6555). Available from: https://doi.org/10.1126/science.abi6226
  13. Chakraborty AK. Coronavirus Nsp2 Protein Homologies to the Bacterial DNA Topoisomerase I and IV Suggest Nsp2 Protein is a Unique RNA Topoisomerase with Novel Target for Drug and Vaccine Development. Virol Mycol. 2020;9:185. Available from: https://www.longdom.org/open-access/coronavirus-nsp2-protein-homologies-to-the-bacterial-dna-topoisomerase-i-and-iv-suggest-nsp2-protein-is-an-unique-rna-topoisomeras-53774.html
  14. Han P, Li L, Liu S, Fu L, Gao GF, Wang P. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell. 2022;185(4):630-640.e10. Available from: https://doi.org/10.1016/j.cell.2022.01.001
  15. Sheward DJ, Kim C, Fischbach J, Sato K, Muschiol S, Ehling RA, et al. Omicron sub-lineage BA.2.75.2 exhibits extensive escape from neutralising antibodies. Lancet Infect Dis. 2022;22(11):1538-1540. Available from: https://doi.org/10.1016/s1473-3099(22)00663-6
  16. Wang Q, Iketani S, Li Z, Liu L, Guo Y, Huang Y, et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2023;186(2):279-286.e8. Available from: https://doi.org/10.1016/j.cell.2022.12.018
  17. Zhang J, Xiao T, Cai Y, Chen B. Structure of SARS-CoV-2 spike protein. Curr Opin Virol. 2021;50:173-182. Available from: https://doi.org/10.1016%2Fj.coviro.2021.08.010
  18. Wang Q, Guo Y, Liu L, Schwanz LT, Li Z, Nair MS, Ho J, et al. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike. Nature. 2023;624(7992):639-644. Available from: https://doi.org/10.1038/s41586-023-06750-w
  19. Chakraborty AK. The 249RWMD spike protein insertion in Omicron BQ.1 subvariant compensates the 24LPP and 69HV deletions and may cause more severe disease than BF.7 and XBB.1 subvariants. Int J Clin Med Edu Res. 2023;2(10):254-270. Available from: https://www.opastpublishers.com/open-access-articles/the-249rwmd-spike-protein-insertion-in-omicron-bq1-subvariant-compensates-the-24lpp-and-69hv-deletions-and-may-cause-sev.pdf
  20. Chakraborty AK. Higher omicron JN.1 and BA.2.86.1 coronavirus transmission due to unique 17MPLF spike insertion compensating 24LPP, 69HV, 145Y, 211N and 483V deletions in the spike. J Future Med Healthcare Innovation. 2024;21(1):1-20. Available from: https://www.opastpublishers.com/open-access-articles/higher-omicron-jn1-and-ba2861-coronavirus-transmission-due-to-unique17-mplf-spike-insertion-compensating-24lpp-69hv-145y.pdf
  21. Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779-782. Available from: https://doi.org/10.1126/science.abb7498
  22. Chakraborty AK. Dynamics of SARS-CoV-2 ORF7a Gene Deletions and Fate of Downstream ORF7b and ORF8 Genes Expression. SunText Rev Biotechnol. 2022;3(1):142. Available from: https://doi.org/10.51737/2766-5097.2022.042
  23. Chakraborty AK. Highly Infectious, Less Pathogenic and Antibody Resistant Omicron Xbb.1, Xbb.1.5 and Xbb.1.5.1- Xbb.1.5.39 Subvariant Coronaviruses Do Not Produce Orf8 Protein Due To 8th Codon Gga=Tga Termination Codon Mutation. Cohesive J Microbiol Infect Dis. 2023;6(5).000648. Available from: https://crimsonpublishers.com/cjmi/pdf/CJMI.000648.pdf
  24. Chakraborty AK. SARS-CoV-2 ORF8 gene CAA=TAA and AAA=TAA termination codon mutations found mostly in B.1.1.7 variant was independent of popular L84S mutations. Int J Clin Med Edu Res. 2022;1(6):192-208. Available from: https://www.opastpublishers.com/open-access-articles/sarscov2-orf8-gene-caataa-and-aaataa-termination-codon-mutations-found-mostly-in-b117-variants-was-independent-of-popula.pdf
  25. Chakraborty AK. Rapid worldwide spread of 17MPLF spike insertion mutants (JN.1-JN.1.25, KP.1, KP.2, KQ.1, KR.1, XDD, XDP, XDK, XDQ subvariants) of omicron coronaviruses and spike gene 5’-end sequencing problem. Res Square. 2024. Available from: https://doi.org/10.21203/rs.3.rs-4741070/v1
  26. Yang Y, Jiang XT, Zhang T. Evaluation of a Hybrid Approach using UBLAST and BLASTX for Metagenomic Sequences Annotation of specific functional genes. PLoS One. 2014;9(10). Available from: https://doi.org/10.1371%2Fjournal.pone.0110947
  27. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403–410. Available from: https://doi.org/10.1016/s0022-2836(05)80360-2
  28. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 1988;16:10881-10890. Available from: https://doi.org/10.1093%2Fnar%2F16.22.10881
  29. Wallace IM, Blackshields G, Higgins DG. Multiple sequence alignments. Curr Opin Struct Biol. 2005;15(3):261–266. Available from: https://doi.org/10.1016/j.sbi.2005.04.002
  30. Sievers F, Wilm A, Dineen DG, Gibson TJ, Karplus K, Li W, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7:539. Available from: https://doi.org/10.1038/msb.2011.75
  31. Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46. Available from: https://doi.org/10.1093%2Fnar%2Fgky427
  32. Studer G, Tauriello G, Bienert S, Biasini M, Johner N, Schwede T. A versatile homology modelling toolbox. PLoS Comput Biol. 2021;17(1). Available from: https://doi.org/10.1371/journal.pcbi.1008667
  33. Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, et al. AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high accuracy models. Nucleic Acids Res. 2022;50. Available from: https://doi.org/10.1093/nar/gkab1061
  34. Zhao J, Qiu J, Aryal S, Hackett JL, Wang J. The RNA Architecture of the SARS-CoV-2 3'-Untranslated Region. Viruses. 2020;12(12):1473. Available from: https://doi.org/10.3390/v12121473
  35. Hendrickson EN, Ericson ME, Bemis LT. Host tRNA-Derived RNAs Target the 3'-Untranslated Region of SARS-CoV-2. Pathogens. 2022;11(12):1479. Available from: https://doi.org/10.3390/pathogens11121479
  36. Hernández-Huerta MT, Pérez-Campos Mayoral L, Matias-Cervantes CA, Romero Díaz C, Cruz Parada E, Pérez-Campos Mayoral E, et al. 3'-UTR of the SARS-CoV-2 genome as a possible source of piRNAs. Genes Dis. 2023;10(3):668-670. Available from: https://doi.org/10.1016/j.gendis.2022.05.028
  37. Pérez-Campos Mayoral L, Hernández-Huerta MT, Romero Díaz C, Matias-Cervantes CA, Pérez-Campos Mayoral E, Martínez Cruz M, et al. Interaction of piRNA-like sequences from the 3'-UTR of SARS-CoV-2 with mRNA regions. Genes Dis. 2023;10(6):2282-4. Available from: https://doi.org/10.1016%2Fj.gendis.2023.01.012
  38. Mukherjee M, Goswami S. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2. PLoS One. 2020;15(8). Available from: https://doi.org/10.1371%2Fjournal.pone.0237559
  39. Meseguer S, Rubio MP, Lainez B, Pérez-Benavente B, Pérez-Moraga R, Romera-Giner S, et al. SARS-CoV-2-encoded small RNAs are able to repress the host expression of SERINC5 to facilitate viral replication. Front Microbiol. 2023;14:1066493. Available from: https://doi.org/10.3389/fmicb.2023.1066493
  40. Hagey RJ, Elazar M, Pham EA, Tian S, Ben-Avi L, Bernardin-Souibgui C, et al. Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2. Nat Med. 2022;28(9):1944-1955. Available from: https://doi.org/10.1038/s41591-022-01908-x
  41. Chakraborty AK. Multi-Alignment Comparison of Coronavirus Non-Structural Proteins Nsp13-16 with Ribosomal Proteins and Other DNA/RNA Modifying Enzymes Suggested Their Roles in the Regulation of Host Protein Synthesis. Int J Clin Med Informatics. 2020;3:7-19. Available from: https://osf.io/preprints/indiarxiv/qrxc5
  42. Zhang J, Cai Y, Lavine CL, Lu J, Xiao T, Chen B. Structural and functional impact by SARS-CoV-2 Omicron spike mutations. Cell Rep. 2022;39(4):110729. Available from: https://doi.org/10.1016/j.celrep.2022.110729
  43. McCallum M, Walls AC, Bowen JE, et al. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nat Struct Mol Biol. 2020;27:942-949. Available from: https://doi.org/10.1038/s41594-020-0483-8
  44. Ou X, Guan H, Qin B, Corti D, Veesler D. Crystal structure of the receptor binding domain of the spike glycoprotein of human betacoronavirus HKU1. Nat Commun. 2017;8:15216. Available from: https://www.nature.com/articles/ncomms15216
  45. Walls AC, Tortorici MA, Bosch BJ, Frenz B, Rottier PJM, DiMaio F, et al. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature. 2016;531(7592):114-117. Available from: https://doi.org/10.1038/nature16988
  46. Dey S, Chakraborty P, Janin J. A survey of haemoglobin quaternary structures. Proteins. 2011;79(10):2861-2870. doi: 10.1002/prot.23112. Available from: https://doi.org/10.1002/prot.23112
  47. Lemmin T, Kalbermatter D, Harder D, Plattet P, Fotiadis D. Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein. J Struct Biol. 2020;4:100038. doi: 10.1016/j.yjsbx.2020.100038. Available from: https://doi.org/10.1016/j.yjsbx.2020.100038
  48. Haseeb M, Amir A, Ikram A. In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants. Vaccines (Basel). 2023 Mar 27;11(4):736. Available from: https://doi.org/10.3390%2Fvaccines11040736
  49. Ortega JT, Jastrzebska B, Rangel HR. Omicron SARS-CoV-2 Variant Spike Protein shows an increased affinity to the Human ACE2 Receptor: An in-silico analysis. Pathogens. 2021;11(1):45. Available from: https://doi.org/10.3390/pathogens11010045
  50. Choi HS, Choi AY, Kopp JB, Winkler CA, Cho SK. Review of COVID-19 therapeutics by mechanism: from discovery to approval. J Korean Med Sci. 2024;39(14). Available from: https://doi.org/10.3346/jkms.2024.39.e134
  51. Wang H, Xue Q, Zhang H, Yuan G, Wang X, Sheng K, et al. Neutralization against omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and ageing despite prototype-based vaccination. Emerg Microbes Infect. 2023;12(2):2249121. Available from: https://doi.org/10.1080/22221751.2023.2249121
  52. Yang S, et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect Dis. 2023;15(23).

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?